Sector | Chemicals | Compare with Sector peers |
Industry | Chemicals | Compare with Industry peers |
Website | http://www.tatvachintan.com | |
Market Cap | 2,525.29 Cr. | |
Enterprise Value(EV) | 2,442.55 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 16.11 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 66.99 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 44.62 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 312.42 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 3.46 | Calculated using Price: 1,079.55 |
Dividend Yield | 0.19 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.34 Cr. | 23,392,055 Shares |
FaceValue | 10 | |
About Tatva Chintan Pharma Chem Ltd. | ||
The company is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. |
1 Day |
|
+0.25% |
1 Week |
|
-7.81% |
1 Month |
|
-13.40% |
3 Month |
|
-32.74% |
6 Month |
|
-31.99% |
1 Year |
|
-35.07% |
2 Year |
|
-51.94% |
5 Year |
|
|
10 Year |
|
6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 20.9 | 28.95 | 38.29 | 36.85 | 30.01 | 9.21 | |
Return on Capital Employed (%) | 19.15 | 22.78 | 28.4 | 28.04 | 25.75 | 8.35 | |
Return on Assets (%) | 8.83 | 12.28 | 17.32 | 18.21 | 19.68 | 6.53 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 62 | 80 | 118 | 166 | 473 | 515 | 727 | |
Non Curr. Liab. | 22 | 35 | 44 | 31 | 5 | -7 | -6 | |
Curr. Liab. | 63 | 73 | 88 | 128 | 171 | 236 | 110 | |
Minority Int. | ||||||||
Equity & Liab. | 147 | 188 | 249 | 325 | 649 | 744 | 831 | |
Non Curr. Assets | 67 | 73 | 116 | 131 | 214 | 430 | 460 | |
Curr. Assets | 80 | 114 | 133 | 195 | 436 | 314 | 371 | |
Misc. Exp. not W/O | ||||||||
Total Assets | 147 | 188 | 249 | 325 | 649 | 744 | 831 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 135 | 206 | 263 | 300 | 434 | 424 | 420 | |
Other Income | 5 | 0 | 1 | 5 | 9 | 6 | 4 | |
Total Income | 140 | 207 | 265 | 306 | 443 | 429 | 424 | |
Total Expenditure | -114 | -172 | -208 | -234 | -325 | -363 | -351 | |
PBIDT | 26 | 35 | 57 | 72 | 118 | 67 | 73 | |
Interest | -3 | -4 | -4 | -4 | -5 | -9 | -10 | |
Depreciation | -4 | -4 | -5 | -7 | -8 | -10 | -22 | |
Taxation | -7 | -7 | -10 | -8 | -8 | 1 | 0 | |
Exceptional Items | 0 | 1 | -4 | -4 | ||||
PAT | 13 | 21 | 38 | 52 | 96 | 45 | 38 | |
Minority Interest | ||||||||
Share Associate | ||||||||
Other Related Items | ||||||||
Consolidated Net Profit | 13 | 21 | 38 | 52 | 96 | 45 | 38 | |
Adjusted EPS | 6 | 10 | 19 | 26 | 43 | 21 | 17 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 7 | 25 | 20 | 20 | 28 | ||
Cash Fr. Inv. | -17 | -40 | -21 | -197 | -101 | ||
Cash Fr. Finan. | 17 | 10 | -5 | 235 | 38 | ||
Net Change | 8 | -5 | -6 | 59 | -36 | ||
Cash & Cash Eqvt | 16 | 11 | 4 | 63 | 27 |
Tue, 26 Mar 2024
Closure of Trading Window Intimation of Closure of Trading Window |
Tue, 26 Mar 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. |
Tue, 19 Mar 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. |
Thu, 28 Mar 2024 |
High Delivery Percentage |
Higher Delivery Quantity |
Higher Delivery Quantity and Percentage |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |